STT
51
-5
LEN
55
-9
IR
72
-5
BAX
30
-3
NTRS
49
-5
ORLY
57
-3
FAST
46
-3
PCAR
50
-3
PSA
66
3
NRG
69
12
FLR
52
4
USB
44
-3
SHW
71
-2
VRSN
53
-2
CMA
62
-2
MMM
52
2
AVGO
69
20
DAL
62
-4
TGNA
48
-2
ADP
69
-3
STT
51
-5
LEN
55
-9
IR
72
-5
BAX
30
-3
NTRS
49
-5
ORLY
57
-3
FAST
46
-3
PCAR
50
-3
PSA
66
3
NRG
69
12
FLR
52
4
USB
44
-3
SHW
71
-2
VRSN
53
-2
CMA
62
-2
MMM
52
2
AVGO
69
20
DAL
62
-4
TGNA
48
-2
ADP
69
-3
Financhill
Back

Global X L/T U.S. Trs Prm Yld ETF USD Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
32

LPAY.U.TO
Global X L/T U.S. Trs Prm Yld ETF USD

Last Price:
20.85
Seasonality Move:
0%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
32
Global X L/T U.S. Trs Prm Yld ETF USD (LPAY.U.TO) is a Sell

Is Global X L/T U.S. Trs Prm Yld ETF USD a Buy, Sell or Hold?

  • The current Global X L/T U.S. Trs Prm Yld ETF USD [LPAY.U.TO] share price is $20.85. The Score for LPAY.U.TO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • LPAY.U.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LPAY.U.TO Stock Price Chart

What is Global X L/T U.S. Trs Prm Yld ETF USD's stock price today?

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

LPAY.U.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 56.91 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.56 - 20.96) Buy
Bollinger Bands (100): (19.85 - 20.63) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

LPAY.U.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.96 Sell
20-day SMA: 20.82 Buy
50-day SMA: 20.51 Buy
200-day SMA: 20.53 Buy
8-day EMA: 20.9 Sell
20-day EMA: 20.81 Buy
50-day EMA: 20.58 Buy
200-day EMA: 6.8 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Global X L/T U.S. Trs Prm Yld ETF USD Earnings Growth & LPAY.U.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Global X L/T U.S. Trs Prm Yld ETF USD Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):